Aratana Therapeutics Inc (NASDAQ:PETX)

5.13
BATS BZX Real-Time Price
As of 3:44pm ET
 +0.05 / +0.98%
Today’s Change
3.67
Today|||52-Week Range
7.67
-2.47%
Year-to-Date

Today’s Trading

Previous close5.08
Today’s open5.07
Day’s range5.00 - 5.13
Volume44,043
Average volume (3 months)489,595
Market cap$183.2M
Data as of 3:44pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+61.22%
Earnings growth (this year)-7.07%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+5,585.99%
P/E ratioNM
Price/Sales6.57
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...+0.27+5.88%
ARDXArdelyx Inc+0.08+1.55%
FBIOFortress Biotech Inc-0.03-0.72%
NLNKNewLink Genetics Cor...+0.17+3.70%
Data as of 3:46pm ET, 04/26/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$38.6M
Annual profit (last year)-$33.6M
Net profit margin-87.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts